🇺🇸 FDA
Patent

US 6677340

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

expired A61PA61P1/00A61P11/00

Quick answer

US patent 6677340 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/00, A61P11/00, A61P13/08, A61P15/00